CD19 and Alzheimer disease: However, MFI of SP expression in CD8+ and CD14+ cells, but not CD4+, CD16+, CD19+ and CD123+HLA-DR− cells, were enhanced in the blood of AD patients compared with HC blood (Fig. 3a, b).